Results 171 to 180 of about 19,814 (246)

Trends in Adoption of Familial Hypercholesterolemia Diagnostic Code E78.01 Across U.S. Health Care Databases, 2016-2024. [PDF]

JACC Adv
Osei J, Najarro G, Sperling L, Khoury MJ, Sun YV.   +4 more
europepmc   +1 more source

Ultra‐processed food addiction in a nationally representative sample of older adults in the USA

Addiction, Volume 121, Issue 3, Page 510-521, March 2026.
Abstract Aims Ultra‐processed foods (UPFs; industrially produced foods typically containing unnaturally elevated levels of refined carbohydrates and/or added fats) became more widely introduced into the United States (US) food environment in the 1980s and have proliferated since. UPFs have been shown to trigger an addictive‐like response.
Lucy K. Loch, Matthias Kirch, Dianne C. Singer, Erica Solway, J. Scott Roberts, Jeffrey T. Kullgren, Ashley N. Gearhardt   +6 more
wiley   +1 more source

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report. [PDF]

J Atheroscler Thromb
Matsuda T, Osaki Y, Matsumoto N, Nakajima R, Murayama Y, Sugano Y, Iwasaki H, Mathis BJ, Sekiya M, Shimano H.   +9 more
europepmc   +1 more source

Alms1 KO Rat: A New Model of Cardiometabolic Syndrome With Spontaneous Hypertension

Acta Physiologica, Volume 242, Issue 3, March 2026.
ABSTRACT Alström syndrome 1 (ALMS1) is a protein linked to Alström syndrome, a rare genetic disorder characterized by obesity, insulin resistance, hyperinsulinemia, and hypertension. Genetic studies have further associated Alms1 with hypertension in human populations. However, the precise mechanisms by which ALMS1 regulates metabolic and cardiovascular
Ankita B. Jaykumar, Sumit R. Monu, Jiang Xu, Mariela Mendez, Xiao‐Ping Yang, Nour‐Eddine Rhaleb, Pablo A. Ortiz   +6 more
wiley   +1 more source

Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns. [PDF]

Nutrients
López-Yerena A, Arroyo-Olivares R, Santisteban V, Muñoz-Garcia N, Estruch R, Mata P, Badimon L, Padro T.   +7 more
europepmc   +1 more source

Quantitative Histological Insights Into Sudden Arrhythmic Death Syndrome: Findings From a Forensic Autopsy Cohort

APMIS, Volume 134, Issue 3, March 2026.
ABSTRACT Sudden arrhythmic death syndrome (SADS) is a major cause of sudden cardiac death in young individuals, characterized by structurally normal hearts and negative toxicology. Although guidelines recommend family screening, phenotyping remains challenging.
Pernille Heimdal Holm, Thomas Hartvig Lindkær Jensen, Joseph Westaby, Mary Sheppard, Stine Bøttcher Jacobsen, Mikkel Eriksen Dupont, Jeppe Dyrberg Andersen, Bo Gregers Winkel, Jacob Tfelt‐Hansen, Jytte Banner, Kristine Boisen Olsen   +10 more
wiley   +1 more source

Prevalence of Familial Hypercholesterolemia and Its Association with Cardiovascular Risk in a Cross-Sectional Adult Population. [PDF]

J Clin Med
Davletov K, Baibolsynova I, Umirbekov N, Auyelbekova A, Lee S, Kulmanbetov R, Kulimbet M.   +6 more
europepmc   +1 more source

Carotid Intima‐Media Thickness as a Marker of Subclinical Atherosclerosis in Adolescents With Severe Haemophilia

Haemophilia, Volume 32, Issue 2, Page 418-424, March/April 2026.
ABSTRACT Background The clinical focus of haemophilia has expanded beyond bleeding outcomes to encompass long‐term comorbidities such as cardiovascular disease (CVD). However, it remains unclear when vascular changes begin in this population. Carotid intima‐media thickness (cIMT), a validated, non‐invasive marker of subclinical atherosclerosis, may ...
Alyson Trillo, Juanita Hunter, Audrey Ofir, Jamie Shoag, Joanna A. Davis, Fernando F. Corrales‐Medina   +5 more
wiley   +1 more source

A Comparative Study of Carotid Ultrasound Findings in Patients With and Without Familial Hypercholesterolemia. [PDF]

Cureus
Nakajima R, Yamazaki H, Kozuma K, Suzuki T, Uno K, Morita K, Ishikawa T, Miyata S, Teramoto T, Tsukamoto K.   +9 more
europepmc   +1 more source

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 3, Page 688-696, March 2026.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani, Larry Charleston IV, Shannon Strom, Detlef Albrecht, Robert Cowan   +4 more
wiley   +1 more source